157 related articles for article (PubMed ID: 20967148)
1. Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.
Lim KA; Kim KC; Cho MS; Lee BE; Kim HS; Hong YM
Korean Circ J; 2010 Sep; 40(9):459-64. PubMed ID: 20967148
[TBL] [Abstract][Full Text] [Related]
2. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
3. Gene expressions of nitric oxide synthase and matrix metalloproteinase-2 in monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.
Koo HS; Kim KC; Hong YM
Korean Circ J; 2011 Feb; 41(2):83-90. PubMed ID: 21430993
[TBL] [Abstract][Full Text] [Related]
4. VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.
Hamidi SA; Lin RZ; Szema AM; Lyubsky S; Jiang YP; Said SI
Respir Res; 2011 Oct; 12(1):141. PubMed ID: 22029879
[TBL] [Abstract][Full Text] [Related]
5. Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.
Son JS; Kim KC; Kim BK; Cho MS; Hong YM
J Korean Med Sci; 2012 Dec; 27(12):1507-16. PubMed ID: 23255850
[TBL] [Abstract][Full Text] [Related]
6. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
7. Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.
Pehlivan Y; Dokuyucu R; Demir T; Kaplan DS; Koc I; Orkmez M; Turkbeyler IH; Ceribasi AO; Tutar E; Taysi S; Kisacik B; Onat AM
Inflammation; 2014 Aug; 37(4):1280-8. PubMed ID: 24604341
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
9. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
10. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
Lourenço AP; Roncon-Albuquerque R; Brás-Silva C; Faria B; Wieland J; Henriques-Coelho T; Correia-Pinto J; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1587-94. PubMed ID: 16679394
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
[TBL] [Abstract][Full Text] [Related]
13. Changes of pulmonary pathology and gene expressions after simvastatin treatment in the monocrotaline-induced pulmonary hypertension rat model.
Lee YH; Kim KC; Cho MS; Hong YM
Korean Circ J; 2011 Sep; 41(9):518-27. PubMed ID: 22022327
[TBL] [Abstract][Full Text] [Related]
14. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.
Clozel M; Hess P; Rey M; Iglarz M; Binkert C; Qiu C
Exp Biol Med (Maywood); 2006 Jun; 231(6):967-73. PubMed ID: 16741032
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension.
Jasmin JF; Lucas M; Cernacek P; Dupuis J
Circulation; 2001 Jan; 103(2):314-8. PubMed ID: 11208695
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ambrisentan Therapy on the Expression of Endothelin Receptor, Endothelial Nitric Oxide Synthase and NADPH Oxidase 4 in Monocrotaline-induced Pulmonary Arterial Hypertension Rat Model.
Lee H; Yeom A; Kim KC; Hong YM
Korean Circ J; 2019 Sep; 49(9):866-876. PubMed ID: 31165592
[TBL] [Abstract][Full Text] [Related]
18. An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model.
Kwon JH; Kim KC; Cho MS; Kim HS; Sohn S; Hong YM
Korean J Pediatr; 2013 Mar; 56(3):116-24. PubMed ID: 23559973
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
20. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]